Puma Biotechnology Aktie
7,56
USD
+0,33
USD
+4,56
%
7,56
USD
+0,32
USD
+4,46
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Puma Biotechnology Aktie Analyse
| 10.05.19 | Puma Biotechnology Neutral | Cantor Fitzgerald | |
| 01.10.18 | Puma Biotechnology Overweight | Cantor Fitzgerald | |
| 11.05.18 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
| 10.11.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 02.10.17 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
| 06.06.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 25.05.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 02.03.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
|
Werbung
|
|||
| 21.09.16 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
| 29.03.16 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 23.01.15 | Puma Biotechnology Outperform | RBC Capital Markets | |
Werbung
Werbung